Skip to content

Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.

An Open, Randomized Study to Compare Two Dental Implant Systems With Regard to Changes in Marginal Bone Level.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00746187
Enrollment
36
Registered
2008-09-03
Start date
2002-12-31
Completion date
2011-06-30
Last updated
2016-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous, Partially

Brief summary

The purpose of this study is to compare marginal bone level changes between ASTRA TECH Implant System; Fixture ST and Biomet 3i; Osseotite® Implants. Subjects with partial edentulism in the posterior maxilla and/or mandible will be included and a one-stage surgical protocol will be used. Implants will be loaded within 15 weeks from installation. The subjects will be followed for 3 years.

Interventions

DEVICEASTRA TECH Implant System; Fixture ST: Ø 4.5 cm in lengths of 9, 11 and 13 mm.
DEVICE3i Osseotite® implant: Ø 4.0 in lengths of 8.5, 10, 11.5 and 13 mm

Sponsors

Dentsply Sirona Implants and Consumables
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Provision of written informed consent * Age 18 - 75 years * Partial edentulism, Kennedy class I or II, last natural tooth must be cuspid or first bicuspid * Edentulous in the area/s if implant placement for more than 2 months

Exclusion criteria

* Untreated caries and/or periodontal disease of residual dentition * Need for pre-surgical bone or soft tissue augmentation in the planned implant area/s. * Absence of occlusal stability in centric occlusion * Any systemic or local disease or condition that would compromise post-operative healing and/or osseointegration * Systemic corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration * Pregnancy * Present alcohol or drug abuse * Tobacco smoking during the last 6 months * Unable or unwilling to return for follow-up visits for a period of 3 years

Design outcomes

Primary

MeasureTime frameDescription
Marginal Bone Level Changes3 years after implant placement (baseline)Marginal bone adaptation was expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at the 3-year follow-up visit were compared to values obtained at Implant placement (baseline). Positive value indicates bone gain and negative value bone loss.

Countries

United States

Participant flow

Participants by arm

ArmCount
ASTRA TECH Implant System; Fixture ST
Ø 4.5 cm in lengths 9-13 mm ASTRA TECH Implant System; Fixture ST: Ø 4.5 cm in lengths of 9, 11 and 13 mm.
18
Biomet 3i; Osseotite® Implants
Ø 4.0 cm in lengths 8.5-13 mm 3i Osseotite® implant: Ø 4.0 in lengths of 8.5, 10, 11.5 and 13 mm
18
Total36

Baseline characteristics

CharacteristicASTRA TECH Implant System; Fixture STBiomet 3i; Osseotite® ImplantsTotal
Age, Continuous55 years
STANDARD_DEVIATION 12
51 years
STANDARD_DEVIATION 11
53 years
STANDARD_DEVIATION 12
Sex: Female, Male
Female
11 Participants12 Participants23 Participants
Sex: Female, Male
Male
7 Participants6 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 180 / 18
serious
Total, serious adverse events
1 / 181 / 18

Outcome results

Primary

Marginal Bone Level Changes

Marginal bone adaptation was expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at the 3-year follow-up visit were compared to values obtained at Implant placement (baseline). Positive value indicates bone gain and negative value bone loss.

Time frame: 3 years after implant placement (baseline)

Population: Per protocol analysis presented and this includes 86 implants in 36 patients. At 3-year follow-up, 74 implants in 31 patients were still in the study and thus evaluable for the analysis.

ArmMeasureValue (MEAN)Dispersion
ASTRA TECH Implant System; Fixture STMarginal Bone Level Changes-0.25 millimeterStandard Deviation 0.6
Biomet 3i; Osseotite® ImplantsMarginal Bone Level Changes-0.50 millimeterStandard Deviation 0.93

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026